Mild cognitive impairment as a diagnostic entity

By Ronald C. Petersen. Journal of Internal Medicine, 2004

7,712 citations recorded by the source corpus.

Subfields: Physiology, Psychiatry and Mental health, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/b6b5e13a5e03147fa970daf67e1c8e010c5ae80c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

In Psychiatry and Mental health

In Public Health, Environmental and Occupational Health

Citations in the corpus

Mild cognitive impairment as a clinical entity and treatment target. (2005, methodology): “A difficult issue arises concerning potential treatments for patients with MCI.”
Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. (2012, background): “However,MCI isaheterogeneoussyndrome, and only 30% to 60% of the patients are affected by prodromal AD, whereas the others have a benign form of cognitive impairment or another neurodegenerative illness.(8) Many studies(9-18) of patients with MCI have shown that abnormalbaseline levels of CSF total ”
Classifying neurocognitive disorders: the DSM-5 approach (2014, methodology): “…criteria for mild neurocognitive dis‑ order must be considered in the context of the other commonly used criteria for MCI: the Mayo Criteria, 16 the International Working Group (IWG) or the Key Symposium Criteria 18,19 and the National Institute of Aging–Alzheimer’s Association (NIA–AA) Criteria.”
Gamification: What It Is and Why It Matters to Digital Health Behavior Change Developers (2013, neutral): “Being able to draw from a worldwide pool of experts and having the ability to establish exhibits which are not possible via a videoconference [14] or a website are also cited as advantages [15,16].”
NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease (2018, neutral): “also has been adopted by many medical practitioners [179].”
Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines (2012, methodology): “Different criteria for defining MCI in the general population have been proposed, and several have undergone revision.6 MCI criteria by Petersen et al.7,8 require (1) a subjective complaint of cognitive decline by the patient, preferably corroborated by a reliable source, (2) minimal effect of the d”
Biomarkers for Alzheimer's disease: current status and prospects for the future (2018, background): “clinical stages of AD gained increasing attention in clinical AD research, and the new term mild cognitive impairment (MCI) was introduced, referring to the transitional state between normal ageing and dementia (84).”
Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade (2010, neutral): “Second is a prodromal phase of AD, commonly referred to as mild cognitive impairment (MCI), 6 which is characterised by the onset of the earliest cognitive symptoms (typically deficits in episodic memory) that do not meet the criteria for dementia.”